REGENXBIO Securities Fraud Class Action
Follow to receive email when new source reporting is added to this case. Email delivery also depends on your profile notification settings and a verified email address.
REGENXBIO · RGX-111 · Ongoing Litigation
Last updated
Case overview
- Defendant company
- REGENXBIO
- Product or service
- RGX-111
- Case status
- Ongoing Litigation
- Lawsuit type
- Securities
- Reported harm
- Misrepresentation
Important dates
- Schall Law Firm Investor Intake
Participation information
Availability is based on each listed participation option and its deadline.
Schall Law Firm Investor Intake
Investors who purchased REGENXBIO securities between February 9, 2022 and January 27, 2026, inclusive, were encouraged to contact the Schall Law Firm regarding the securities class action.
Contact the Schall Law Firm to discuss rights and potential participation.
- Type
- Law Firm Signup
- Status
- Deadline passed
- Reported proof requirement
- Unclear
This information does not determine whether you qualify for a case.
Sources
Public reporting associated with this case.
- REGENXBIO Securities Fraud Class Action
Barchart.com ·